Target intelligence / Profile preview

High mobility group box 1 protein (HMGB1)

Target
HMGB1
Molecular classification
Non-histone chromatin-binding protein, Damage-associated molecular pattern (DAMP) molecule, Alarmin
01

Overview

High mobility group box protein B (HMGB1) is an evolutionarily conserved non-histone nuclear protein encoded by the HMGB1 gene. It plays critical roles inside cells—organizing DNA structure, regulating transcription through chromatin remodeling—and outside cells where it acts as a prototypical alarmin/DAMP. Upon cell activation or injury (such as necrosis), HMGB1 translocates from nucleus to cytoplasm then is secreted into the extracellular space where it functions like a cytokine. Extracellularly released/secreted HMGB1 triggers inflammatory responses by binding pattern recognition receptors including TLRs (notably TLR2/TLR4), amplifying innate immunity during both sterile injury and infection. Its dysregulation contributes to pathogenesis across diverse conditions such as sepsis, autoimmune diseases (e.g., rheumatoid arthritis), cardiovascular disease (e.g., atherosclerosis), cancer immunity modulation, among others. Therapeutic strategies targeting extracellular HMGB1—such as neutralizing antibodies—are under investigation for their potential benefit in controlling excessive inflammation without compromising essential homeostatic functions.

Other names
high-mobility group protein 1HMG-1amphoterin
02

Mechanism of action

Neutralization of extracellular HMGB1 to reduce inflammation and tissue damage by blocking its interaction with receptors such as TLR2/TLR4. Modulation of immune response by interfering with DAMP signaling. Inhibition of downstream cytokine release from macrophages/monocytes.

03

Biological functions

DNA organization and bending in the nucleusRegulation of gene transcriptionChromatin remodelingCytokine activity when secreted extracellularlyActivation of immune responses and inflammationRegulation of autophagy/apoptosis balance
04

Disease associations

Inflammation (including sterile and infectious)SepsisRheumatoid arthritisAtherosclerosisCancer/tumor immunity modulation via immune activation
05

Safety considerations

Targeting HMGB1 may impair normal tissue repair processes due to its role in regeneration.Broad immunomodulation could increase risk for infection or interfere with host defense mechanisms.Potential off-target effects due to widespread expression and multiple cellular functions.
06

Interacting drugs

Antibodies that neutralize HMGB1 have been studied for protection against tissue injury in diseases such as arthritis, colitis, ischemia, sepsis, endotoxemia, and systemic lupus erythematosus. Specific drug names are not provided in the search results but anti-HMGB1 antibodies are under investigation as therapeutics.

1 more in the full profile.

07

Biomarkers

Extracellular levels of HMGB1 can serve as biomarkers for inflammatory diseases including sepsis and autoimmune disorders.Used to monitor disease severity or therapeutic efficacy in clinical studies.

Beyond the preview

Go deeper on High mobility group box 1 protein (HMGB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 protein (HMGB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call